Bortezomib, lyophilisate (powder), 2.5 mg each

By: MUNICIPAL NON-COMMERCIAL ENTERPRISE OF LVIV REGIONAL COUNCIL "LVIV ONCOLOGY REGIONAL TREATMENT AND DIAGNOSTIC CENTER"๐Ÿ“ UkraineOpen

Key Information

ReferenceGB-UA-2026-08-12-007449-a
DeadlineDec 31, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryUkraine
AddressUA
PublishedAug 12, 2026

Description

Bortezomib, lyophilisate (powder), 2.5 mg each

Full details are available after unlocking this tender.